Skip to main content
Find People
Campus Map
PiratePort
A-Z
English
العربية
বাংলা
Català
Čeština
Deutsch
Ελληνικά
Español
Suomi
Français
Gàidhlig
हिंदी
Magyar
Italiano
Қазақ
Latviešu
Nederlands
Polski
Português
Português do Brasil
Srpski (lat)
Српски
Svenska
Türkçe
Yкраї́нська
Tiếng Việt
Log In
Log in
Have you forgotten your passphrase?
Communities & Collections
Browse
Statistics
About
Submit
Home
Health Sciences Campus
Brody School of Medicine
Microbiology and Immunology
Synergistic Effects of Selective Inhibitors Targeting the PI3K/AKT/mTOR Pathway or NUP214-ABL1 Fusion Protein in Human Acute Lymphoblastic Leukemia
Synergistic Effects of Selective Inhibitors Targeting the PI3K/AKT/mTOR Pathway or NUP214-ABL1 Fusion Protein in Human Acute Lymphoblastic Leukemia
Files
McCubreySynergisticCytotoxicEffectsofBortezomibandCK2Inhibitor.pdf
(4.55 MB)
Date
2016-11-03
Authors
McCubrey, James A.
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Description
Keywords
NUP214-ABL1
,
PI3K/Akt/mTOR signaling
,
T-Acute Lymphoblastic Leukemia
Citation
URI
http://hdl.handle.net/10342/9629
Collections
Microbiology and Immunology
Full item page